Aave and Morpho continue in their fight for market dominance on Base. Same-transaction supply flows directly between the two protocols picked up in July, reaching nearly $35m in reallocated supply. Although the same-transaction supply shifts are small relative to the total supply of the protocols, it is a potentially useful indicator of who's strategy is working at attracting capital. For example, in Q1 this year Morpho managed to attract over $28.5m directly away from Aave, while Aave only attracted $3.5m from Morpho. In Q2 the flows reversed with Aave edging Morpho out attracting $27.9m from its competitors supply, compared to Morpho's $25.3.